Presented annually since 2009, the Winthrop P. Rockefeller Cancer Institute Seeds of Science Awards assist cancer researchers in collecting data and developing projects that have the potential to result in significant research findings.
This year we had a record number of applicants and have supported a record number of investigators. These efforts directly support our mission to achieve NCI designation.
The following four Cancer Institute members will receive $50,000 individual pilot awards:
In addition to supporting novel ideas from individual Cancer Institute members, we also support team science by funding groups of laboratories that join forces to address challenging cancer research questions. The following research teams will receive $100,000 each to support their work.
$100,000 Team Awards
Sayem Miah, Ph.D., Mohammad Rahman, Ph.D., and Stephanie Byrum, Ph.D., assistant professors in the Department of Biochemistry and Molecular Biology. Loss of FAM60A promotes HBB induced mammary gland tumorigenesis.
Bolni “Marius” Nagalo, Ph.D., assistant professor in the Department of Pathology, Martin Cannon, Ph.D., professor in the Department of Microbiology and Immunology and Alexei Basnakian, M.D., Ph.D., professor in the Department of Pharmacology & Toxicology. Immunotherapy of hepatocellular carcinoma by live attenuated vaccine vectors.
Samantha Kendrick, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology and Brendan Frett, Ph.D., assistant professor in the Department of Pharmaceutical Sciences. NEK2 kinase as a new oncogenic vulnerability in lymphoma.
Justin Leung, Ph.D., assistant professor in the Department of Radiation Oncology and Brian Koss, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology. Functional ORFeome atlas.
Adam Wolfe, M.D., Ph.D., assistant professor in the Department of Radiation Oncology, Isabelle Racine Miousse, Ph.D., assistant professor in the Department of Biochemistry & Molecular Biology and Nukhet Aykin-Burns, Ph.D., associate professor in the Department of Pharmaceutical Sciences. Synergizing methionine restriction with radiation therapy in KRAS mutant rectal cancer.
Kevin Raney, Ph.D., professor, Eric Enemark, Ph.D., associate professor, Robert Eoff, Ph.D., professor – all in the Department of Biochemistry & Molecular Biology – and Karl Boehme, Ph.D., associate professor in the Department of Microbiology & Immunology. Helicases, Non-Canonical DNA and Their Links to Cancer through Innate Immunity.
Hong-yu Li, Ph.D., professor in the Department of Pharmaceutical Sciences and Zhiqiang Qin, M.D., Ph.D., associate professor in the Department of Pathology. Development of Potent Dual HDACs/BRD4 Inhibitors for the Treatment of Virus-associated Lymphomas.